Skip to main content
. 2018 Sep 21;8(57):32621–32636. doi: 10.1039/c8ra06362a

Fig. 5. Therapeutic efficacy of morusin-loaded niosomes and free morusin towards (a and b) HT-29 (c and d) PANC-1 (e and f) MDA-MB-453 (g and h) SKOV-3 and (i and j) L929 cell line. Compared to the free drug, more inhibition was observed in the case of morusin-loaded niosomes in all cell lines.

Fig. 5